Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro

Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aureus (MRSA) infection for many years. However, the rise of MRSA infection rates and the extensive use of vancomycin have led to the emergence of reduced vancomycin susceptibility. Therefore, four typic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Med (Wars)
Asıl Yazarlar: Xu, Jia, Pang, Long, Ma, Xiao Xue, Hu, Jian, Tian, Yuan, Yang, Ya Li, Sun, Dan Dan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: De Gruyter 2018
Konular:
Regular Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6227741/
https://ncbi.nlm.nih.gov/pubmed/30426085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2018-0071
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller